Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish Population-based Cohort Study
Open Access
- 2 May 2006
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (9) , 1339-1341
- https://doi.org/10.1038/sj.bjc.6603123
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsAnnals of the Rheumatic Diseases, 2005
- Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish womenActa Obstetricia et Gynecologica Scandinavica, 2005
- Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort studyBritish Journal of Cancer, 2005
- Lymphoma: Diagnosis, staging, natural history, and treatment strategiesSeminars in Oncology, 2005
- Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV SeroconvertersAIDS, 2004
- The validity of self‐reported use of hormone replacement therapy among Danish nursesActa Obstetricia et Gynecologica Scandinavica, 2004
- Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversionAIDS, 2004
- Reproductive Factors in Hodgkin's Disease in WomenAmerican Journal of Epidemiology, 2003
- Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.2002
- Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesisArchives of Toxicology, 1984